Literature DB >> 26798729

Hybrid Antegrade Thoracic Aortic Stenting via a Temporary Ascending Aortic Graft Conduit for a Patient with Poor Peripheral Vascular Access.

Randolph H L Wong1, Simon C H Yu2, C M Chu2, Innes Y P Wan1, Rainbow W H Lau1, Calvin S H Ng1, Malcolm J Underwood1.   

Abstract

In patients with poor peripheral vascular access, thoracic aortic stenting procedures can be technically very challenging. Antegrade aortic stent deployments during concomitant open ascending and arch procedures are well described, but the issue of long endovascular catheters and wires may make such an approach difficult and awkward. We describe a novel hybrid method involving a temporary graft conduit to the ascending aorta which is brought caudal toward the foot of the table to facilitate antegrade deployment of the thoracic stent graft.

Entities:  

Keywords:  Aortic operation; Endovascular procedures; Hybrid theater

Year:  2014        PMID: 26798729      PMCID: PMC4682755          DOI: 10.12945/j.aorta.2014.14-006

Source DB:  PubMed          Journal:  Aorta (Stamford)        ISSN: 2325-4637


  4 in total

Review 1.  Technical solutions for common problems in TEVAR: managing access and aortic branches.

Authors:  Frank J Criado; Christine McKendrick; Francis R Criado
Journal:  J Endovasc Ther       Date:  2009-02       Impact factor: 3.487

2.  Special iliac artery considerations during aneurysm endografting.

Authors:  J P Henretta; L A Karch; K J Hodgson; M A Mattos; D E Ramsey; R McLafferty; D S Sumner
Journal:  Am J Surg       Date:  1999-09       Impact factor: 2.565

3.  Antegrade delivery of stent grafts to treat complex thoracic aortic disease.

Authors:  Eric E Roselli; Edward G Soltesz; Tara Mastracci; Lars G Svensson; Bruce W Lytle
Journal:  Ann Thorac Surg       Date:  2010-08       Impact factor: 4.330

4.  Modified four-branched graft technique without circulatory arrest and antegrade thoracic endovascular aortic repair for extensive thoracic aorta reconstruction.

Authors:  Chia-Hsun Lin
Journal:  Ann Thorac Surg       Date:  2012-12       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.